1. Home
  2. FOLD vs SSRM Comparison

FOLD vs SSRM Comparison

Compare FOLD & SSRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Amicus Therapeutics Inc.

FOLD

Amicus Therapeutics Inc.

HOLD

Current Price

$14.36

Market Cap

4.4B

Sector

Health Care

ML Signal

HOLD

Logo SSR Mining Inc.

SSRM

SSR Mining Inc.

HOLD

Current Price

$23.93

Market Cap

4.5B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
FOLD
SSRM
Founded
2002
1946
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Precious Metals
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
4.4B
4.5B
IPO Year
2007
1996

Fundamental Metrics

Financial Performance
Metric
FOLD
SSRM
Price
$14.36
$23.93
Analyst Decision
Buy
Hold
Analyst Count
9
5
Target Price
$27.56
$21.89
AVG Volume (30 Days)
21.4M
2.7M
Earning Date
02-18-2026
02-17-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
1.05
Revenue
$598,704,000.00
$1,431,099,000.00
Revenue This Year
$21.49
$57.69
Revenue Next Year
$18.46
$44.90
P/E Ratio
N/A
$22.71
Revenue Growth
21.28
30.30
52 Week Low
$5.51
$7.03
52 Week High
$14.36
$25.98

Technical Indicators

Market Signals
Indicator
FOLD
SSRM
Relative Strength Index (RSI) 89.94 63.16
Support Level $14.26 $21.38
Resistance Level $14.35 $22.87
Average True Range (ATR) 0.05 0.99
MACD -0.12 0.15
Stochastic Oscillator 100.00 74.90

Price Performance

Historical Comparison
FOLD
SSRM

About FOLD Amicus Therapeutics Inc.

Amicus Therapeutics Inc is a patient-dedicated biotechnology company focused on discovering, developing and delivering novel high-quality medicines for people living with rare diseases. With extraordinary patient focus, the company is committed to advancing and expanding a pipeline of cutting-edge medicines for rare diseases. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of therapies to treat a range of devastating rare and orphan diseases.

About SSRM SSR Mining Inc.

SSR Mining Inc is a minerals company focused on mining precious metals in the Americas. More than half of Silver Standard's revenue is attributable to the production of gold, with a key portion derived from silver production. The company owns and operates the Marigold mine in Nevada, United States; the Seabee Gold Operation in Saskatchewan, Canada; and the Puna mine in Argentina. The majority of gold production is derived from the Marigold mine, and Silver Standard's silver production is principally derived from the Puna mine.

Share on Social Networks: